Book of abstracts

IFCC, President & EFLM, Past-President (current)Laboratory Medicine (LabMed) plays a critical role in enhancing the quality of healthcare by delivering accurate, precise, and timely laboratory test results.These results support evidence-based clinical decisions, contributing to more effective and targeted therapies, reduced morbidity, risk prediction and reduction, improve treatment compliance, and better monitoring of recovery and therapeutic outcomes.LabMed ultimately shortens hospital stays, reduces the risk of hospital-acquired infections, and improves patients' quality of life.Laboratory Medicine and In Vitro Diagnostics (IVD) represent a sound and strategic investment in healthcare, encompassing a broad spectrum of technologies-from cutting-edge technologies performed in advanced clinical laboratories to user-friendly point of care and self-testing.The global IVD market is expected to double over the next decade, driven by an aging population and the rising burden of non-communicable and chronic diseases across both developed and emerging economies.This growth is occurring despite increasing pressures to demonstrate medical value, navigate complex regulatory frameworks, and manage economic constraints.Next-generation Point-of-Care Testing (POCT) platforms are expected to grow slightly faster than central laboratory markets.The implementation of the In Vitro Diagnostic Regulation (IVDR) is transforming the landscape for IVD companies, redefining product development, lifecycle management, and commercialization strategies.Clinical evidence must demonstrate scientific validity, analytical and clinical performance, and their interconnected roles in performance evaluation. Key Challenges inLaboratory Medicine are Data Security and Privacy: Ensuring patient data protection and